30 Day Trial

ORTHOWORLD » Other Articles of Interest

Private equity groups weigh Biomet exit

Biomet's private equity owners may relist the company six years after taking it private. The owners may also consider selling Biomet in a "dual track," in which an entity files for an IPO while listening to buyout offers.

Read the full story in Financial Times and FierceMedicalDevices.

Also see the Journal-Gazette, "Equity owners may act to sell stake in Biomet"

0 COMMENTS

Name
Comment